DIA Annual Meeting, In Brief

Executive Summary

FDA retention bonuses: CDER is "aggressively looking at retention bonuses for staff," Office of New Drugs Director John Jenkins, MD, tells Drug Information Association annual meeting in Chicago June 20. "Some of our review disciplines have already received retention bonuses across the board to try to maintain those staff. We are looking at other initiatives to improve the quality of work life such as the ability to...work at home, which many people find rewarding." The Office of New Drugs is in the process of developing a "comprehensive recruitment and retention plan," Jenkins said. Although the staff turnover rate at CDER "hasn't changed that dramatically over the past decade...it is still unacceptably high"...